Financhill
Back

IGM Biosciences Quote, Financials, Valuation and Earnings

IGM Biosciences Price Quote

$10.13
-1.09 (-9.71%)
(Updated: November 14, 2024 at 5:55 PM ET)

IGM Biosciences Key Stats

Buy
51
IGM Biosciences (IGMS) is a Buy

Day range:
$11.12 - $12.20
52-week range:
$4.55 - $22.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
234.60
P/B ratio:
5.52%

Volume:
173K
Avg. volume:
231.2K
1-year change:
141.29%
Market cap:
$675M
Revenue:
$2.1M
EPS:
$-3.64

How Much Does IGM Biosciences Make?

Is IGM Biosciences Growing As A Company?

  • What Is IGM Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.8%
  • What Is IGM Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

IGM Biosciences Stock Price Performance

  • Did IGM Biosciences Stock Go Up Last Month?
    IGM Biosciences share price went down by -25.2% last month
  • Did IGMS's Share Price Rise Over The Last Year?
    IGMS share price rose by 141.29% over the past 1 year

What Is IGM Biosciences 52-Week High & Low?

IGM Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy IGM Biosciences?

  • How Much Debt Does IGM Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does IGM Biosciences Have?
    Cash and short term investments quarterly total is $256.4M
  • What Is IGM Biosciences’s Book Value Per Share?
    Book value per share is 2.07

Is IGM Biosciences Cash Flow Positive?

  • What Is IGMS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$167.9M
  • What Is IGM Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $45.8M
  • What Is IGM Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $38M

IGM Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    IGMS return on invested capital is -110.28%
  • What Is IGM Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -52.7%
  • What Is IGMS Return On Equity?
    ROE is a measure of profitability and is -110.28%

IGM Biosciences Earnings Date & Stock Price

IGM Biosciences Competitors

  • Who Are IGM Biosciences's Competitors?
    Below is a list of companies who compete with IGM Biosciences or are related in some way:
    • iBio Inc (IBIO)
    • Moderna Inc (MRNA)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

IGM Biosciences Dividend Yield

IGM Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -26.71%
Revenue: 179.91% 113.03%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 19.60
Upside from Last Price: 74.69%

Major Shareholders

  • How many IGMS shares are owned by institutional investors?
    39.5M IGMS shares are owned by institutional investors
  • How many IGMS shares are owned by insiders?
    1.7M IGMS shares are owned by insiders